Product Details

Chlorpheniramine + Dexamethasone Injection BP delivers a high-quality combination therapy that meets British Pharmacopoeia (BP) standards. This fixed-dose injectable combination manages acute allergic and inflammatory conditions, combining antihistamine and corticosteroid action in a single parenteral formulation for I.M./I.V. use.

The injection combines:

• Chlorpheniramine Maleate, an antihistamine that relieves allergic symptoms by blocking histamine H1 receptors, reducing itching, swelling, and allergic reactions, and
• Dexamethasone Sodium Phosphate, a corticosteroid that reduces inflammation and suppresses acute allergic and hypersensitivity responses by suppressing the body’s inflammatory pathways.

Doctors commonly prescribe this combination for acute allergic reactions, anaphylaxis (as adjunct therapy), angioedema, and other conditions requiring rapid anti-allergic and anti-inflammatory intervention. Hospitals, clinics, and emergency care settings rely on this formulation for its consistent quality and dependable therapeutic results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP-standard compliant injectable combination therapy
• Manages acute allergic reactions and inflammatory conditions
• Delivers combined antihistamine and corticosteroid action
• Contains Chlorpheniramine 10 mg + Dexamethasone 4 mg per mL
• For I.M./I.V. use only, suited for rapid clinical response
• Maintains a high-purity, sterile formulation
• Suits hospital, emergency care, and clinical use